Aditxt, Inc. announced on October 9, 2026, that its wholly-owned subsidiary, Ignite Proteomics, LLC, has terminated a previously announced business combination agreement with Copley Acquisition Corp. The termination was executed via a Mutual Termination Agreement signed by the parties on that date.
The original Business Combination Agreement was executed on June 10, 2026. The agreement involved Copley Acquisition Corp, Ignite Proteomics Holdings Inc., Ignite Merger Sub I Inc., Ignite Merger Sub II LLC, and representatives Jeffrey M. Busch and Chibo Tang. Under the terms of the termination, the agreement was mutually ended effective immediately pursuant to Section 8.1(a) of the original contract.
As a result of the termination, all parties are released from further rights, remedies, and liabilities regarding the transaction, with the exception of specific sections of the agreement that survive. Additionally, all ancillary documents associated with the merger, including Seller Support Agreements, Insider Letter Amendments, and Lock-Up Agreements, were terminated concurrently with the Business Combination Agreement.
Aditxt filed the Mutual Termination Agreement as Exhibit 10.1 to this Current Report on Form 8-K. The company noted that the filing contains forward-looking statements regarding the potential effects of the termination on its business, operations, and financial condition.
